X-Received: by 2002:a5d:604a:0:b0:21b:9517:66eb with SMTP id j10-20020a5d604a000000b0021b951766ebmr302189wrt.494.1655852718443;
Tue, 21 Jun 2022 16:05:18 -0700 (PDT)
X-Received: by 2002:a05:6902:12ca:b0:65c:a34c:39cf with SMTP id
j10-20020a05690212ca00b0065ca34c39cfmr607134ybu.476.1655852717708; Tue, 21
Jun 2022 16:05:17 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder8.news.weretis.net!proxad.net!feeder1-2.proxad.net!209.85.128.87.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.lang.fortran
Date: Tue, 21 Jun 2022 16:05:17 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=91.219.212.90; posting-account=HpZpEgoAAACNQOrFpoyZmdNwd-5Pp8S9
NNTP-Posting-Host: 91.219.212.90
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <7c3ab9e8-7b9c-4d6d-833b-058197b2d836n@googlegroups.com>
Subject: (PDF) Cancer Immunotherapy Principles and Practice by Lisa H. Butterfield
From: hesterholt6@gmail.com (hester holt)
Injection-Date: Tue, 21 Jun 2022 23:05:18 +0000
Content-Type: text/plain; charset="UTF-8"